{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:29:13Z","timestamp":1707524953422},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,27]]},"DOI":"10.7759\/cureus.36769","type":"journal-article","created":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T04:27:38Z","timestamp":1679977658000},"source":"Crossref","is-referenced-by-count":0,"title":["Endophthalmitis After Intravitreal Bevacizumab (Avastin) Injections: An Outbreak Investigated"],"prefix":"10.7759","author":[{"given":"Khawaja K","family":"Shoaib","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Awaid","family":"Abid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saad","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.47391\/JPMA.212","article-title":"Incidence of endophthalmitis following intravitreal anti VEGF injections at a tertiary care hospital in Pakistan","volume":"71","author":"Shaheen F","year":"2021","unstructured":"Shaheen F, Awan MA, Hafeez A, Haq A, Malik RZ. Incidence of endophthalmitis following intravitreal anti VEGF injections at a tertiary care hospital in Pakistan. J Pak Med Assoc. 2021, 71:1184-8. 10.47391\/JPMA.212","journal-title":"J Pak Med Assoc"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3341\/kjo.2022.0088","article-title":"Incidence of acute endophthalmitis after intravitreal antivascular endothelial growth factor injection in age-related macular degeneration","volume":"36","author":"Seong HJ","year":"2022","unstructured":"Seong HJ, Park YM, Kim J, Son KJ, Chung EJ. Incidence of acute endophthalmitis after intravitreal antivascular endothelial growth factor injection in age-related macular degeneration. Korean J Ophthalmol. 2022, 36:435-42. 10.3341\/kjo.2022.0088","journal-title":"Korean J Ophthalmol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-022-02489-x","article-title":"Incidence and visual outcomes of acute endophthalmitis post intravitreal injection of anti-vascular endothelial growth factors in a single referral center","author":"Gonzalez-Gonzalez LA","year":"2022","unstructured":"Gonzalez-Gonzalez LA, Knickelbein JE, Doft BH, Balasubramani GK, Wisniewski S. Incidence and visual outcomes of acute endophthalmitis post intravitreal injection of anti-vascular endothelial growth factors in a single referral center. Int Ophthalmol. 2022, 10.1007\/s10792-022-02489-x","journal-title":"Int Ophthalmol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/08820538.2021.1896746","article-title":"Incidence and outcomes of endophthalmitis with in-house compounded intravitreal bevacizumab injections: a multicentric study","volume":"36","author":"Sen S","year":"2021","unstructured":"Sen S, Mishra C, Kannan NB, Ramasamy K, Rameshkumar G, Lalitha P. Incidence and outcomes of endophthalmitis with in-house compounded intravitreal bevacizumab injections: a multicentric study. Semin Ophthalmol. 2021, 36:413-22. 10.1080\/08820538.2021.1896746","journal-title":"Semin Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjo.2021.06.015","article-title":"Impact of patient face mask use on endophthalmitis after intravitreal anti-VEGF injections","volume":"57","author":"H\u00e9bert M","year":"2022","unstructured":"H\u00e9bert M, You E, Hammamji K, Bourgault S, Caissie M, Tourville \u00c9, Dirani A. Impact of patient face mask use on endophthalmitis after intravitreal anti-VEGF injections. Can J Ophthalmol. 2022, 57:364-9. 10.1016\/j.jcjo.2021.06.015","journal-title":"Can J Ophthalmol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11030876","article-title":"Safety measures for maintaining low endophthalmitis rate after intravitreal anti-vascular endothelial growth factor injection before and during the COVID-19 pandemic","volume":"11","author":"Tanaka K","year":"2022","unstructured":"Tanaka K, Shimada H, Mori R, Kitagawa Y, Onoe H, Tamura K, Nakashizuka H. Safety measures for maintaining low endophthalmitis rate after intravitreal anti-vascular endothelial growth factor injection before and during the COVID-19 pandemic. J Clin Med. 2022, 11:876. 10.3390\/jcm11030876","journal-title":"J Clin Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1159\/000518236","article-title":"The effect of syringe-filling technique on the risk for endophthalmitis after intravitreal injection of anti-VEGF agents","volume":"245","author":"Finkelstein M","year":"2022","unstructured":"Finkelstein M, Katz G, Zur D, Rubowitz A, Moisseiev E. The effect of syringe-filling technique on the risk for endophthalmitis after intravitreal injection of anti-VEGF agents. Ophthalmologica. 2022, 245:34-40. 10.1159\/000518236","journal-title":"Ophthalmologica"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2020.1820530","article-title":"Does pharmaceutical compounding of vascular endothelial growth factor inhibitors for intravitreal use alter the risk of post-injection endophthalmitis?","volume":"30","author":"Blom K","year":"2022","unstructured":"Blom K, Bragad\u00f3ttir R, Sivertsen MS, Moe MC, J\u00f8rstad \u00d8K. Does pharmaceutical compounding of vascular endothelial growth factor inhibitors for intravitreal use alter the risk of post-injection endophthalmitis?. Ocul Immunol Inflamm. 2022, 30:713-6. 10.1080\/09273948.2020.1820530","journal-title":"Ocul Immunol Inflamm"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3928\/23258160-20210528-03","article-title":"Rates of suspected endophthalmitis following intravitreal injections in clinical practices in the United States","volume":"52","author":"Dhoot DS","year":"2021","unstructured":"Dhoot DS, Boucher N, Pitcher JD 3rd, Saroj N. Rates of suspected endophthalmitis following intravitreal injections in clinical practices in the United States. Ophthalmic Surg Lasers Imaging Retina. 2021, 52:312-8. 10.3928\/23258160-20210528-03","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0278625","article-title":"Clinical characteristics and risk factors for visual prognosis according to the types of infectious endophthalmitis","volume":"17","author":"Lee JJ","year":"2022","unstructured":"Lee JJ, Jo YJ, Lee JS. Clinical characteristics and risk factors for visual prognosis according to the types of infectious endophthalmitis. PLoS One. 2022, 17:e0278625. 10.1371\/journal.pone.0278625","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/ICB.0000000000001084","article-title":"Delayed-onset streptococcus intermedius endophthalmitis following anti-vascular endothelial growth factor intravitreal injection","volume":"16","author":"Mercer GD","year":"2022","unstructured":"Mercer GD, Politis M, Campagnoli TR, Galic IJ, Chen JC. Delayed-onset streptococcus intermedius endophthalmitis following anti-vascular endothelial growth factor intravitreal injection. Retin Cases Brief Rep. 2022, 16:688-90. 10.1097\/ICB.0000000000001084","journal-title":"Retin Cases Brief Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.12669\/pjms.38.8.5125","article-title":"Safety of simultaneous bilateral intravitreal versus unilateral anti-vasculo-endothelial growth factors injection in an operating room setting","volume":"38","author":"Jeeva IK","year":"2022","unstructured":"Jeeva IK, Masud S, Siddiqui MA, Fahad HM. Safety of simultaneous bilateral intravitreal versus unilateral anti-vasculo-endothelial growth factors injection in an operating room setting. Pak J Med Sci. 2022, 38:2324-30. 10.12669\/pjms.38.8.5125","journal-title":"Pak J Med Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/aos.14504","article-title":"Bilateral endophthalmitis following bilateral same-day anti-VEGF injections","volume":"99","author":"Sepetis AE","year":"2021","unstructured":"Sepetis AE, Clarke B, Gupta B. Bilateral endophthalmitis following bilateral same-day anti-VEGF injections. Acta Ophthalmol. 2021, 99:e131-3. 10.1111\/aos.14504","journal-title":"Acta Ophthalmol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S276620","article-title":"Evaluation of the safety of bilateral same-day intravitreal injections of anti-vascular endothelial growth factor agents: experience of a large Korean retina center","volume":"14","author":"Jang K","year":"2020","unstructured":"Jang K, Ahn J, Sohn J, Hwang DD. Evaluation of the safety of bilateral same-day intravitreal injections of anti-vascular endothelial growth factor agents: experience of a large Korean retina center. Clin Ophthalmol. 2020, 14:3211-8. 10.2147\/OPTH.S276620","journal-title":"Clin Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2020.1808229","article-title":"Klebsiella cluster endophthalmitis following intravitreal bevacizumab: role of early detection, pars plana vitrectomy, and intracameral moxifloxacin","volume":"30","author":"Kohli GM","year":"2022","unstructured":"Kohli GM, Shenoy P, Malhotra PP, Tripathi S, Shetty S, Sen A. Klebsiella cluster endophthalmitis following intravitreal bevacizumab: role of early detection, pars plana vitrectomy, and intracameral moxifloxacin. Ocul Immunol Inflamm. 2022, 30:11-5. 10.1080\/09273948.2020.1808229","journal-title":"Ocul Immunol Inflamm"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-021-02180-7","article-title":"Incidence and management of acute endophthalmitis after intravitreal injection of bevacizumab","volume":"42","author":"Karimi S","year":"2022","unstructured":"Karimi S, Fakhri N, Ansari I, Hassanpour K, Safi S. Incidence and management of acute endophthalmitis after intravitreal injection of bevacizumab. Int Ophthalmol. 2022, 42:1827-33. 10.1007\/s10792-021-02180-7","journal-title":"Int Ophthalmol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2018.11.023","article-title":"The impact of prefilled syringes on endophthalmitis following intravitreal injection of ranibizumab","volume":"199","author":"Storey PP","year":"2019","unstructured":"Storey PP, Tauqeer Z, Yonekawa Y, et al.. The impact of prefilled syringes on endophthalmitis following intravitreal injection of ranibizumab. Am J Ophthalmol. 2019, 199:200-8. 10.1016\/j.ajo.2018.11.023","journal-title":"Am J Ophthalmol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3928\/23258160-20200603-05","article-title":"Management and visual outcomes of acute bacterial endophthalmitis following intravitreal injection of contaminated bevacizumab in a single day","volume":"51","author":"Xu K","year":"2020","unstructured":"Xu K, Mousa R, Loewenstein A, Barak A, Chin EK, Almeida DR. Management and visual outcomes of acute bacterial endophthalmitis following intravitreal injection of contaminated bevacizumab in a single day. Ophthalmic Surg Lasers Imaging Retina. 2020, 51:346-52. 10.3928\/23258160-20200603-05","journal-title":"Ophthalmic Surg Lasers Imaging Retina"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/140145-endophthalmitis-after-intravitreal-bevacizumab-avastin-injections-an-outbreak-investigated","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:58:34Z","timestamp":1707508714000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/140145-endophthalmitis-after-intravitreal-bevacizumab-avastin-injections-an-outbreak-investigated"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,27]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.36769","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,27]]}}}